Advertisement

Enhancement of cAMP-mediated inotropic responses by CNP is regulated differently by PDE2 in normal and failing hearts

  • Silja Meier
  • Kjetil Wessel Andressen
  • Jan Magnus Aronsen
  • Ivar Sjaastad
  • Tor Skomedal
  • Jan-Bjørn Osnes
  • Eirik Qvigstad
  • Finn Olav Levy
  • Lise Román Moltzau
Open Access
Meeting abstract

Keywords

Heart Failure PDE2 Inhibition Inotropic Response Natriuretic Peptide Level Coronary Artery Ligation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Background

Natriuretic peptide levels are increased in heart failure (HF). Atrial (ANP) and brain (BNP) natriuretic peptide mediate their effects preferentially through the natriuretic peptide receptor (NPR)-A, and C-type natriuretic peptide (CNP) through NPR-B. NPRs are membrane bound guanylyl cyclases that increase cyclic GMP (cGMP) production when activated. We have previously shown that NPR-B stimulation by CNP enhances β1-adrenoceptor (β1-AR)- and 5-HT4 serotonin receptor-mediated signaling in failing hearts, probably through inhibition of phosphodiesterase (PDE) 3, a potential detrimental effect in the failing heart. In this study we examine the role of PDE2 in regulating the CNP-induced enhancement of β1-AR and 5-HT4 signaling in non-failing (Sham) and failing (HF) hearts, as PDE2 is a dual-selective PDE and can potentially be stimulated by cGMP.

Methods

Chronic heart failure was induced in male Wistar rats by 6-week coronary artery ligation. Contractility studies were performed ex vivo in left ventricular muscle strips in the presence of appropriate receptor agonist and antagonists. cGMP measurements were performed on isolated left ventricular cardiomyocytes and PDE activity assays on left ventricular cardiomyocyte homogenates.

Results

CNP, by stimulating NPR-B, was able to enhance β1-AR- and 5-HT4-mediated inotropic responses in Sham and HF left ventricular strips. CNP elicited a similar increase of cGMP in cardiomyocytes from Sham and HF. cGMP reduced the cAMP-PDE activity of PDE3 and increased the cAMP-PDE activity of PDE2 concentration-dependently in cardiomyocyte homogenates in a similar way in Sham and HF. In Sham inhibition of PDE2 by EHNA amplified the CNP-induced enhancement of β1-AR- and 5-HT4-mediated inotropic responses. In HF PDE2 inhibition did not influence the functional effects of CNP despite increasing the cGMP response to the same marked extent as in Sham.

Conclusions

There is a preserved mechanism of CNP-induced enhancement of β1-AR and 5-HT4 in Sham and HF. cGMP levels and cGMP-mediated activation and inhibition of cAMP-PDE activity of PDE2 and PDE3, respectively, are similar in Sham and HF. However, PDE2 seems more involved in regulating the β1-AR and 5-HT4 enhancement in Sham compared to HF, which might reflect differences between Sham and HF in PDE2 expression or compartmentation.

Copyright information

© Meier et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Silja Meier
    • 1
    • 2
  • Kjetil Wessel Andressen
    • 1
    • 2
  • Jan Magnus Aronsen
    • 2
    • 3
    • 4
  • Ivar Sjaastad
    • 2
    • 3
  • Tor Skomedal
    • 1
    • 2
  • Jan-Bjørn Osnes
    • 1
    • 2
  • Eirik Qvigstad
    • 1
    • 2
  • Finn Olav Levy
    • 1
    • 2
  • Lise Román Moltzau
    • 1
    • 2
  1. 1.Department of PharmacologyUniversity of Oslo and Oslo University HospitalOsloNorway
  2. 2.K.G. Jebsen Cardiac Research Centre and Center for Heart Failure ResearchUniversity of OsloOsloNorway
  3. 3.Institute for Experimental Medical ResearchUniversity of Oslo and Oslo University HospitalOsloNorway
  4. 4.Bjørknes CollegeOsloNorway

Personalised recommendations